Endocrine responses to long-term administration of the antiprogesterone RU486 in patients with pelvic endometriosis (Q39507740)

12 September 2017

title

Endocrine responses to long-term administration of the antiprogesterone RU486 in patients with pelvic endometriosis (English)

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(16)54531-2

6 November 2022

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1716596

6 November 2022

biology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1716596

6 November 2022

sex organ

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1716596

6 November 2022

genitourinary system

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1716596

6 November 2022

physiology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1716596

glyco-Lutropin [extracellular region]

6 November 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1716596

6 November 2022

prospective cohort study

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1716596

6 November 2022

pituitary gonadotropins

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1716596

6 November 2022

developed country

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1716596

female reproductive system

6 November 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1716596

6 November 2022

hormone antagonist

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1716596

6 November 2022

Menstruation disorders

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1716596

6 November 2022

L. M. Kettel

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1716596

6 November 2022

A. A. Murphy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1716596

6 November 2022

J. F. Mortola

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1716596

6 November 2022

J. H. Liu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1716596

6 November 2022

A. Ulmann

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1716596

6 November 2022

S. S. Yen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1716596

6 November 2022

language of work or name

English

0 references

publication date

1 September 1991

1 reference

full work available at URL

12 September 2017

https://api.elsevier.com/content/article/PII:S0015028216545312?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(16)54531-2

https://api.elsevier.com/content/article/PII:S0015028216545312?httpAccept=text/plain

6 November 2022

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(16)54531-2

6 November 2022

published in

Fertility and Sterility

1 reference

12 September 2017

1 reference

12 September 2017

1 reference

12 September 2017

page(s)

402-407

1 reference

Contragestion and other clinical applications of RU 486, an antiprogesterone at the receptor

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954531-2

7 January 2021

Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954531-2

7 January 2021

Effects of the antiprogesterone steroid RU 486 during midluteal phase in normal women

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954531-2

7 January 2021

Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954531-2

7 January 2021

Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954531-2

7 January 2021

Immunohistochemical analysis of estrogen and progesterone receptors in endometriosis: comparison with normal endometrium during the menstrual cycle and the effect of medical therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954531-2

7 January 2021

Revised American Fertility Society classification of endometriosis: 1985

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954531-2

7 January 2021

Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954531-2

7 January 2021

Effects of the antiprogesterone RU486 in the early follicular phase of the menstrual cycle.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954531-2

7 January 2021

Blockade of the spontaneous midcycle gonadotropin surge in monkeys by RU 486: a progesterone antagonist or agonist?

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954531-2

7 January 2021

Endometrial and pituitary responses to the steroidal antiprogestin RU 486 in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954531-2

7 January 2021

Blockade by Progesterone of Estrogen—Induced LH and FSH Release in the Rhesus Monkey12

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954531-2

7 January 2021

Roles of Estradiol and Progesterone in Eliciting the Midcycle Luteinizing Hormone and Follicle-Stimulating Hormone Surges*

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954531-2

7 January 2021

RU 486 (mifepristone): induction of dose dependent elevations of estradiol receptor in endometrium from ovariectomized monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954531-2

7 January 2021

The New Steroid Analog RU 486 Inhibits Glucocorticoid Action in Man

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954531-2

7 January 2021

Pharmacodynamics of the antiprogesterone RU486 in women after oral administration

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2954531-2

7 January 2021

A novel general biophysical model for simulating episodic endocrine gland signaling

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(16)54531-2

Antiprogestins, a new form of endocrine therapy for human breast cancer

6 November 2022

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(16)54531-2

The antiprogestin RU486 in advanced breast cancer: preliminary clinical trial

6 November 2022

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(16)54531-2

6 November 2022

Identifiers

0 references

1 reference